Anlon Healthcare (NSE:AHCL) Total Operating Expense: ₹175 Mil (TTM As of Mar. 2026)


NSE:AHCL Anlon Healthcare Ltd NSE:AHCL
28 GF Score
Price ₹15.87
! 5 Warning Signs
View Full Analysis

What is Anlon Healthcare Total Operating Expense?

Anlon Healthcare NSE:AHCL -0.19% 28 Total Operating Expense is ₹175 Mil as of Mar. 2026. GuruFocus rates NSE:AHCL with a GF Score™ of 28/100. The stock has 5 warning signs investors should review.

Anlon Healthcare's Total Operating Expense for the three months ended in Mar. 2026 was ₹80 Mil. Anlon Healthcare's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹175 Mil.

Anlon Healthcare Total Operating Expense Related Terms

Anlon Healthcare Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Anlon Healthcare's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anlon Healthcare Total Operating Expense Chart

Anlon Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
92.17 134.13 162.91 152.65 208.72

Anlon Healthcare Quarterly Data
Mar22 Mar23 Mar24 Jun24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.38 49.41 59.57 35.18 80.41
NSE:AHCL
28GF Score
Anlon Healthcare Ltd NSE:AHCL
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anlon Healthcare Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹175 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹175 Mil mean?
Anlon Healthcare (NSE:AHCL) has a Total Operating Expense of ₹175 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Anlon Healthcare and its competitors.
Is Anlon Healthcare's Total Operating Expense too high?
Anlon Healthcare's current Total Operating Expense is ₹175 Mil. Overall, Anlon Healthcare has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's Total Operating Expense compare to ZTS and UTHR?
Anlon Healthcare's Total Operating Expense of ₹175 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Anlon Healthcare and its competitors. Anlon Healthcare's current Total Operating Expense is ₹175 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current Total Operating Expense of ₹175 Mil. The current Total Operating Expense is ₹175 Mil. Anlon Healthcare's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current Total Operating Expense is ₹175 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anlon Healthcare Business Description

Other Exchanges 544497:India
Address Kalawad Road, 101/102, Silvercoin Complex, Opposite Crystal Mall, Rajkot, GJ, IND, 360 005
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
28GF Score

Get the complete analysis for NSE:AHCL

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.87
Price